4.8 Review

Molecular Roadblocks for Cellular Reprogramming

期刊

MOLECULAR CELL
卷 47, 期 6, 页码 827-838

出版社

CELL PRESS
DOI: 10.1016/j.molcel.2012.09.008

关键词

-

资金

  1. National Institutes of Health (NIH) [RC4 NS073015-01, R01MH092931, AG010770-18A1]
  2. California Institute for Regenerative Medicine (CIRM) [DR1-01454, RT2-02061]
  3. Department of Defense [PR100175P1]
  4. Ellison Medical Foundation
  5. Stinehart-Reed Foundation
  6. Baxter Foundation

向作者/读者索取更多资源

During development, diverse cellular identities are established and maintained in the embryo. Although remarkably robust in vivo, cellular identities can be manipulated using experimental techniques. Lineage reprogramming is an emerging field at the intersection of developmental and stem cell biology in which a somatic cell is stably reprogrammed into a distinct cell type by forced expression of lineage-determining factors. Lineage reprogramming enables the direct conversion of readily available cells from patients (such as skin fibroblasts) into disease-relevant cell types (such as neurons and cardiomyocytes) or into induced pluripotent stem cells. Although remarkable progress has been made in developing novel reprogramming methods, the efficiency and fidelity of reprogramming need to be improved in order increase the experimental and translational utility of reprogrammed cells. Studying the mechanisms that prevent successful reprogramming should allow for improvements in reprogramming methods, which could have significant implications for regenerative medicine and the study of human disease. Furthermore, lineage reprogramming has the potential to become a powerful system for dissecting the mechanisms that underlie cell fate establishment and terminal differentiation processes. In this review, we will discuss how transcription factors interface with the genome and induce changes in cellular identity in the context of development and reprogramming.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据